Basit öğe kaydını göster

dc.contributor.authorYazıcı, Gözde
dc.contributor.authorKurt Vatandaşlar, Burcu
dc.contributor.authorAydın Cantürk, İlknur
dc.contributor.authorAydınlı, Fatmagül İlayda
dc.contributor.authorArıcı Düz, Özge
dc.contributor.authorKarakoç, Emre
dc.contributor.authorKerman, Bilal Ersen
dc.contributor.authorAlkan, Can
dc.date.accessioned2023-05-15T13:55:30Z
dc.date.available2023-05-15T13:55:30Z
dc.date.issued2023en_US
dc.identifier.citationYazıcı, G., Kurt Vatandaşlar, B., Aydın Cantürk, İ., Aydınlı, F. İ., Arıcı Düz, Ö., Karakoç, E. ... Alkan, C. (2023). Identification of protein-protein interaction bridges for multiple sclerosis. Bioinformatics, 39(4). https://doi.org/10.1093/bioinformatics/btad175en_US
dc.identifier.issn1367-4803
dc.identifier.issn1367-4811
dc.identifier.urihttps://doi.org/10.1093/bioinformatics/btad175
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10944
dc.description.abstractMotivation: Identifying and prioritizing disease-related proteins is an important scientific problem to develop proper treatments. Network science has become an important discipline to prioritize such proteins. Multiple sclerosis, an autoimmune disease for which there is still no cure, is characterized by a damaging process called demyelination. Demyelination is the destruction of myelin, a structure facilitating fast transmission of neuron impulses, and oligodendrocytes, the cells producing myelin, by immune cells. Identifying the proteins that have special features on the network formed by the proteins of oligodendrocyte and immune cells can reveal useful information about the disease.Results: We investigated the most significant protein pairs that we define as bridges among the proteins providing the interaction between the two cells in demyelination, in the networks formed by the oligodendrocyte and each type of two immune cells (i.e. macrophage and T-cell) using network analysis techniques and integer programming. The reason, we investigated these specialized hubs was that a problem related to these proteins might impose a bigger damage in the system. We showed that 61%-100% of the proteins our model detected, depending on parameterization, have already been associated with multiple sclerosis. We further observed the mRNA expression levels of several proteins we prioritized significantly decreased in human peripheral blood mononuclear cells of multiple sclerosis patients. We therefore present a model, BriFin, which can be used for analyzing processes where interactions of two cell types play an important role.en_US
dc.language.isoengen_US
dc.publisherOxford University Pressen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectT-CELLSen_US
dc.subjectMyelinen_US
dc.subjectAtlasen_US
dc.titleIdentification of protein-protein interaction bridges for multiple sclerosisen_US
dc.typearticleen_US
dc.relation.ispartofBioinformaticsen_US
dc.departmentİstanbul Medipol Üniversitesi, Rektörlük, Sağlık Bilim ve Teknolojileri Araştırma Enstitüsüen_US
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Nöroloji Ana Bilim Dalıen_US
dc.authorid0000-0003-0334-811Xen_US
dc.authorid0000-0003-1106-3288en_US
dc.identifier.volume39en_US
dc.identifier.issue4en_US
dc.relation.tubitakinfo:eu-repo/grantAgreement/TUBITAK/SOBAG/1001-218S495
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1093/bioinformatics/btad175en_US
dc.institutionauthorKurt Vatandaşlar, Burcu
dc.institutionauthorAydınlı, Fatmagül İlayda
dc.institutionauthorArıcı Düz, Özge
dc.institutionauthorKerman, Bilal Ersen
dc.identifier.wosqualityQ1en_US
dc.identifier.wos000975574900002en_US
dc.identifier.scopus2-s2.0-85160769134en_US
dc.identifier.pmid37018152en_US
dc.identifier.scopusqualityQ1en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess